➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Mallinckrodt
Harvard Business School
Colorcon
Boehringer Ingelheim

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Litigation Details for LEO Pharma A/S v. Perrigo UK FINCO Limited Partnership (D. Del. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

LEO Pharma A/S v. Perrigo UK FINCO Limited Partnership (D. Del. 2016)

Docket   Start Trial Date Filed 2016-06-10
Court District Court, D. Delaware Date Terminated 2018-09-26
Cause 35:271 Patent Infringement Assigned To Joseph F. Bataillon
Jury Demand None Referred To Sherry R. Fallon
Parties LEO LABORATORIES LIMITED
Patents 6,432,452; 6,787,161; 6,844,013; 7,141,237; 7,410,656; 8,278,292; 8,372,827; 8,372,828; 8,377,919; 8,536,163; 8,716,271; 8,735,375; 9,820,959; 9,833,428; 9,833,429
Attorneys Khurram Naik
Firms Richards, Layton & Finger, PA
Link to Docket External link to docket
Small Molecule Drugs cited in LEO Pharma A/S v. Perrigo UK FINCO Limited Partnership
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for LEO Pharma A/S v. Perrigo UK FINCO Limited Partnership (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-06-10 1 of U.S. Patent No. 6,432,452 (“the ’452 Patent”), U.S. Patent No. 6,787,161 (“the ’161 Patent”), U.S.…’452 Patent, the ’161 Patent, the ’013 Patent, the ’656 Patent, the ’292 Patent, the ’827 Patent, the…the ’828 Patent, the ’919 Patent, the ’163 Patent, the ’271 Patent, and the ’375 Patent. 30. …U.S. Patent No. 6,844,013 (“the ’013 Patent”), U.S. Patent No. 7,410,656 (“the ’656 Patent”), U.S. Patent…8,278,292 (“the ’292 Patent”), U.S. Patent No. 8,372,827 (“the ’827 Patent”), U.S. Patent No. 8,372,828 ( External link to document
2017-12-15 156 and Initial Infringement Charts for U.S. Patent Nos. 9,820,959; 9,833,428; 9,833,429 filed by LEO Laboratories… 26 September 2018 1:16-cv-00430 830 Patent None District Court, D. Delaware External link to document
2018-02-22 217 Supplemental Infringement Charts for U.S. Patent Nos. 8,278,292; 9,820,959; 9,833,428; and 9,833,429; (10…Plaintiffs' Supplemental Infringement Charts for U.S. Patent Nos. 9,416,084 and 9,676,698; (12) Plaintiffs' … 26 September 2018 1:16-cv-00430 830 Patent None District Court, D. Delaware External link to document
2018-03-12 233 Initial Invalidity Contentions Regarding U.S. Patent Nos. 9,820,959, 9,833,428 and 9,833,429 filed by Perrigo… 26 September 2018 1:16-cv-00430 830 Patent None District Court, D. Delaware External link to document
2018-04-12 257 STIPULATION of Dismissal with respect to U.S. Patent Nos. 6,787,161 and 6,844,013 by LEO Laboratories Limited… 26 September 2018 1:16-cv-00430 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson
AstraZeneca
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.